Crystec Limited
Research and experimental development on biotechnology · Bradford
ActiveUnited KingdomIncorporated 2007Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-12-31
IXBRL · 141 source facts · 20 selected values
Validation cleanXBRL valid
Accounts to 2025-12-31
IXBRL · 141 source facts · 20 selected values
Validation clean
XBRL valid
- Reporting period
- 2025-01-01 to 2025-12-31
- Extraction status
- complete
- Numeric facts
- 86
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- valid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2606_06401897_20251231
- Source archive
- Accounts_Monthly_Data-June2026.zip
Registered details
06401897- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2007-10-17
- Jurisdiction
- —
- Registered office
- UNIT 41, LISTERHILLS SCIENCE PARK, BRADFORD, BD7 1HR, ENGLAND
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
3 matched grantsNewton Fund - Accelerating cost-effective development of improved treatments for COPD and other respirtory diseases in ChinaLeadInnovate UK · Collaborative R&D · 2017-04-01 – 2020-03-31 · with 1 other participant£576,830awarded
Newton Fund - Accelerating cost-effective development of improved treatments for COPD and other respirtory diseases in ChinaLead
Innovate UK · Collaborative R&D · 2017-04-01 – 2020-03-31 · with 1 other participant
£576,830
awarded
Crystec Limitedlead£576,830
Novel treatment for Raynaud's phenomenaLead
Innovate UK · GRD Proof of Market · 2016-05-01 – 2016-08-31
£24,858
awarded
A Novel Therapy for Treatment of Urinary IncontinenceLead
Innovate UK · GRD Proof of Concept · 2012-09-01 – 2014-02-28
£100,000
awarded